Clinical distribution and drug resistance of Enterobacter cloacae
Qiang XIE,Ming-jie CAO,Jin-li WANG,Tian-tian XU,Xiao-ling MA
DOI: https://doi.org/10.11816/cn.ni.2015-140483
2015-01-01
Abstract:OBJECTIVE To understand the clinical distribution and drug resistance of the Enterobacter cloacae strains so as to provide guidance for reasonable clinical use of antibiotics .METHODS From Jan 2013 to Dec 2013 , totally 39 strains of E .cloacae isolated from clinical specimens were retrospectively analyzed ,then the bacterial i‐dentification was carried out by using MicroScan WalkAway 96 PLUS automatic bacteria analyzer of the United States and its matched NC50 detection card ,the drug susceptibility testing was conducted ,and the statistical anal‐ysis was performed with the use of WHONET5 .6 software .RESULTS Of the 39 E .cloacae isolates ,56 .4% were isolated from sputum specimens ,25 .6% were isolated from secretions ,and 10 .3% were isolated from urine speci‐mens ;as for the distribution of departments ,25 .6% were isolated from the department of pediatrics ,18 .0% were isolated from the ICU ,10 .3% were isolated from the department of burns and plastic surgery ,and 10 .3% were i‐solated from the neonatal department .The drug resistance rates of the 39 E .cloacae isolates to imipenem ,mero‐penem ,amikacin ,levofloxacin ,piperacillin‐tazobactam ,and ciprofloxacin were 10 .3% ,12 .8% ,20 .5% ,28 .2% , 30 .8% ,and 30 .8% ,respectively ;the strains were the most susceptible to carbapenems antibiotics .CONCLUSION The isolated E .cloacae strains are highly drug‐resistant ,and it is necessary for the microbiological laboratory to strengthen the surveillance of the resistance .